Price, DavidRyan, DermotBurden, AnnieVon Ziegenweidt, JulieGould, ShunaFreeman, DarylGruffydd-Jones, KevinCopland, AnneGodley, CliffordChisholm, AlisonThomas, Mike2014-10-132014-10-132013-11-07Price, D, Ryan, D, Burden, A, Von Ziegenweidt, J, Gould, S, Freeman, D, Gruffydd-Jones, K, Copland, A, Godley, C, Chisholm, A & Thomas, M 2013, 'Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care', Clinical and Translational Allergy, vol. 3, no. 1, pp. 37. https://doi.org/10.1186/2045-7022-3-372045-7022http://hdl.handle.net/2164/3712Acknowledgements We thank Robin Taylor for his informative thinking and publications on FeNO, which have helped to influence and direct the thinking of the authors. Funding Extraction of the real-life dataset was funded by Research in Real Life Limited, the analysis of the dataset and the writing of this manuscript were co-funded (50:50) by Research in Real Life Limited and Aerocrine.673434engfractional exhaled nitric oxide (FeNO)practical guidancediagnosison-going asthma managementsteroid-responsive diseaseR MedicineRJournal article10.1186/2045-7022-3-3731